Kathleen Tregoning, M.A
Overview
Kathleen Tregoning, M.A received $4M in total compensation, including $193K in salary, at Cerevel Therapeutics Holdings in 2020.
Source: SEC filing on April 28, 2021.
Related executives
We found eight more executives who work or worked at Cerevel Therapeutics Holdings.
N Coles
Cerevel Therapeutics Holdings
Chief Executive Officer
Abraham Ceesay
Cerevel Therapeutics Holdings
President
Kathy Yi
Cerevel Therapeutics Holdings
Chief Financial Officer
Raymond Sanchez
Cerevel Therapeutics Holdings
Chief Medical Officer
Scott Akamine
Cerevel Therapeutics Holdings
Chief Legal Officer
Mark Bodenrader
Cerevel Therapeutics Holdings
Chief Financial Officer
Bryan Phillips
Cerevel Therapeutics Holdings
Chief Legal Officer
John Renger
Cerevel Therapeutics Holdings